Fusion Pharmaceuticals Price on December 3, 2024

FUSNDelisted Stock  USD 3.75  0.33  8.09%   
If you're considering investing in Fusion Stock, it is important to understand the factors that can impact its price. As of today, the current price of Fusion Pharmaceuticals stands at 3.75, as last reported on the 4th of December, with the highest price reaching 4.08 and the lowest price hitting 3.75 during the day. We have found thirty technical indicators for Fusion Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Fusion Pharmaceuticals' Mean Deviation of 2.86, coefficient of variation of 6981.69, and Downside Deviation of 3.45 to check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Fusion Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
FUSN
Based on monthly moving average Fusion Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Fusion Pharmaceuticals by adding Fusion Pharmaceuticals to a well-diversified portfolio.

Related Headline

Pmv Pharmaceuticals Headline on 3rd of December 2024

As the U.S. stock market reaches new heights with record closings for the SP 500 and Nasdaq, investors are exploring diverse opportunities beyond large-cap tech stocks. Penny stocks, while often associated with smaller or newer companies, remain a relevant area for those seeking unique investment possibilities. Despite their vintage-sounding name, these stocks can offer surprising value when backed by strong financials, providing potential for significant returns and stability.

Fusion Pharmaceuticals Valuation on December 3, 2024

It is possible to determine the worth of Fusion Pharmaceuticals on a given historical date. On December 3, 2024 Fusion was worth 4.08 at the beginning of the trading date compared to the closed value of 3.75. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Fusion Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Fusion Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Fusion Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Fusion Pharmaceuticals' related companies.
 Open High Low Close Volume
12/04/2024
  4.08    4.08    3.75    3.75    0.00  
Backtest Fusion Pharmaceuticals  |  Fusion Pharmaceuticals History  |  Fusion Pharmaceuticals Valuation 
Open Value
4.08
3.75
Closing Value
4.08
Upside

Fusion Pharmaceuticals Trading Date Momentum on December 3, 2024

Fusion Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Fusion Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Fusion Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Fusion financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Fusion Pharmaceuticals Stock history

Fusion Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Fusion is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Fusion Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Fusion Pharmaceuticals stock prices may prove useful in developing a viable investing in Fusion Pharmaceuticals
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. Fusion Pharmaceuticals Inc. was incorporated in 2014 and is headquartered in Hamilton, Canada. Fusion Pharmaceuticals is traded on NASDAQ Exchange in the United States.

Fusion Pharmaceuticals Stock Technical Analysis

Fusion Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Fusion Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Fusion Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Fusion Pharmaceuticals Period Price Range

Low
December 4, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Fusion Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Fusion Pharmaceuticals December 4, 2024 Market Strength

Market strength indicators help investors to evaluate how Fusion Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Fusion Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Fusion Pharmaceuticals stock market strength indicators, traders can identify Fusion Pharmaceuticals entry and exit signals to maximize returns

Fusion Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Fusion Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Fusion Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Fusion to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Consideration for investing in Fusion Stock

If you are still planning to invest in Fusion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Fusion Pharmaceuticals' history and understand the potential risks before investing.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Fundamental Analysis
View fundamental data based on most recent published financial statements
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Bonds Directory
Find actively traded corporate debentures issued by US companies
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA